FFA
CAI

Farther Finance Advisors’s Caris Life Sciences CAI Stock Holding History

Farther Finance Advisors’s Portfolio CAI Stock Details CAI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.28K Sell
128
-4
-3% -$72 ﹤0.01% 5125
2026
Q1 		$2.52K Buy
132
+103
+355% +$2.25K ﹤0.01% 4804
2025
Q4 		$782 Buy
+29
New +$817 ﹤0.01% 4962

Other funds holding CAI

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
JHWEPV
J. H. Whitney Equity Partners VI New Canaan, Connecticut $201M AUM
Coatue Management
Coatue Management New York $48.6B AUM 94.27% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return
SSP
Sixth Street Partners Dallas, Texas $579M AUM 2.46% 1-Year Est. Return
PC
PointState Capital New York $7.82B AUM 43.51% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Farther Finance Advisors's CAI Position: Q2 2026 in Review

Farther Finance Advisors reduced its Caris Life Sciences (CAI) stake by 3% in Q2 2026, selling an estimated $72 and leaving 128 shares worth $2.28K. The position accounts for ﹤0.01% of the portfolio, ranked #5125.

Farther Finance Advisors first reported a position in CAI in Q4 2025 and has held it in 3 quarters since. The position peaked at $2.52K in Q1 2026. 246 funds tracked by Wall St. Rank hold CAI as of Q2 2026.

  • Farther Finance Advisors held 128 shares of Caris Life Sciences worth $2.28K as of Q2 2026.
  • Farther Finance Advisors sold 4 Caris Life Sciences shares in Q2 2026, an estimated $72.
  • Caris Life Sciences made up ﹤0.01% of Farther Finance Advisors's portfolio in Q2 2026, its #5125 holding.
  • Farther Finance Advisors first reported a position in Caris Life Sciences in Q4 2025 and has held it in 3 quarters since.
  • Farther Finance Advisors's Caris Life Sciences position peaked at $2.52K in Q1 2026.
  • 246 funds tracked by Wall St. Rank held Caris Life Sciences as of Q2 2026.

Based on Farther Finance Advisors's 13F filing for Q2 2026, filed 17 Jul 2026.